Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review of Metabolic Targets of Anticancer Nutrients and Nutraceuticals in Pre-Clinical Models of Triple-Negative Breast Cancer
Alleigh Wiggs, Sabrina Molina, Susan Sumner, et al.
Nutrients (2022) Vol. 14, Iss. 10, pp. 1990-1990
Open Access | Times Cited: 16

Showing 16 citing articles:

A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges
Vivek Puri, Manju Nagpal, Inderbir Singh, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4637-4637
Open Access | Times Cited: 136
Metabolomics of Breast Cancer: A Review
Ramadevi Subramani, Seeta Poudel, Kenneth Smith, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 643-643
Open Access | Times Cited: 35
Metabolomics Analysis Reveals Novel Targets of Chemosensitizing Polyphenols and Omega-3 Polyunsaturated Fatty Acids in Triple Negative Breast Cancer Cells
Blake R. Rushing, Alleigh Wiggs, Sabrina Molina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4406-4406
Open Access | Times Cited: 17
Ferroptosis as a promising targeted therapy for triple negative breast cancer
Kasra Mokhtarpour, Sepideh Razi, Nima Rezaei
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 3, pp. 497-513
Closed Access | Times Cited: 6
Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics
Shiliang Chen, Yingxue Fei, Xiaoli Cai, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Malnutrition management in oncology: An expert view on controversial issues and future perspectives
Paolo Bossi, Raffaele De Luca, Oriana Ciani, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
n-3 PUFAs synergistically enhance the efficacy of doxorubicin by inhibiting the proliferation and invasion of breast cancer cells
Pradnya Gurav, Tanvi Patade, Shubham Hajare, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 6
Commonalities in Metabolic Reprogramming between Tobacco Use and Oral Cancer
Blake R. Rushing, Spencer Tilley, Sabrina Molina, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 10261-10261
Open Access | Times Cited: 9
Nutritional Metabolomics in Diet–Breast Cancer Relations: Current Research, Challenges, and Future Directions—A Review
Farhad Vahid, Kimia Hajizadeghan, Adeleh Khodabakhshi
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1845-1845
Open Access | Times Cited: 4
Antrodia salmonea suppresses epithelial-mesenchymal transition/metastasis and Warburg effects by inhibiting Twist and HIF-1α expression in Twist-overexpressing head and neck squamous cell carcinoma cells
Jhih‐Hsuan Hseu, Yi‐An Lin, Sudhir Pandey, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117030-117030
Closed Access | Times Cited: 4
The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs
Weijun Pan, Kai Song, Yunli Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer
Kankan Zhao, Yuan Zheng, Wenliang Lu, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 3
Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents
Blake R. Rushing
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13242-13242
Open Access | Times Cited: 2
Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer
Irena Padzińska-Pruszyńska, Paulina Kucharzewska, Agata Matejuk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10781-10781
Open Access
n-3 PUFAs synergistically enhance the efficacy of Doxorubicin by inhibiting the proliferation and invasion of breast cancer cells
Pradnya Gurav, Tanvi Patade, Shubham Hajare, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Cytotoxic, antioxidant, and cytoprotective properties of polyphenol‐enriched extracts from pecan nutshells in MDA‐MB‐231 breast cancer cells
Lucas E. Ribas, Fátima Belén Gasser, M.E. Baravalle, et al.
Cell Biochemistry and Function (2023) Vol. 41, Iss. 8, pp. 1442-1450
Closed Access
Page 1

Scroll to top